Investors and Partners
Investors & partners
Our Partners
Vaccitech is seeking partners in the development of its programs for infectious diseases and cancers. We have entered into non-exclusive licensure of our platforms for use in oncology, and remain committed to advancing the use of cancer vaccines, either with or without checkpoint inhibitors.
Oxford Sciences Innovation find the most innovative ideas coming out of Oxford, and invest in them to build world-class companies.
The University of Oxford is a collegiate research university located in Oxford, England, United Kingdom. While having no known date of foundation, there is evidence of teaching as far back as 1096, making it the oldest university in the English-speaking world and the world’s second-oldest surviving university.
Emergent BioSolutions provides specialty products for civilian and military populations that address intentional and naturally emerging public health threats.
Batavia Biosciences accelerates the transition of biopharmaceutical candidates from discovery to the clinic with improved success rates and lower costs.
Oxford Genetics improves the design and development of biological therapeutics via DNA design and the optimisation of virus and protein expression systems.
Oxford University Innovation is a wholly-owned subsidiary of the University of Oxford. OUI manages the University’s technology transfer and consulting activities and provide an innovation management service to clients around the world.
Oxford University Hospitals (OUH) is a world renowned centre of clinical excellence and one of the largest NHS teaching trusts in the UK. Theye became a Foundation Trust on 1 October 2015 and believe that this will enable them to work more effectively in partnership with their patients and their local community to provide high quality healthcare.